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ABSTRACT Ischemic/reperfusion injury (IRI) causes acute kidney injury that may lead to chronic kidney disease. We inves-
tigated the correlation between kidney interstitial cells expansion, hemoglobin level, and erythropoietin expression as the
chronic effects of single and repeated kidney IRI inmice. We created an IRImodel usingmale Swissmice by clamping the bilat-
eral renal pedicles. Subjects were divided into four groups that contained sixmice each: control/sham operation, single acute
IRI, single chronic IRI, and repeated IRI. Our results showed that the single chronic and repeated IRI groups significantly in-
creased the tubular injury score, decreased thehemoglobin level, and increased erythropoietin expression comparedwith the
control. Lowerhemoglobin levels in all of thegroups comparedwith the controlwasassociatedwitherythropoietin resistance.
In single chronic and repeated kidney IRI, there were decreased creatinine levels compared with the control. The decreased
creatinine levels from the single acute IRI group to the single chronic IRI group, suggesting a repair phase of IRI starting on
day 7 occurred in the single chronic IRI group. A macrophage marker, CD68, and an inflammatory mediator marker, MCP-1,
significantly increased in all IR groups, indicating inflammationoccurreddue to IRI. In conclusion, chronic and repeated kidney
IRI induced interstitial cells expansion and inflammation associated with anemia.
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1. Introduction
Chronic Kidney Disease (CKD) is a major health problem
in both developed and developing countries (Prodjosud-
jadi and Suhardjono 2009). The progression of this dis-
ease into end-stage renal disease is difficult to avoid and
the mortality rate still remains higher than 20% per year,
even with the availability of dialysis. Based on data pub-
lished by the National Kidney Foundation, the number of
patients treated with dialysis and kidney transplantation
has increased dramatically in the United States. More than
400,000 Americans suffered from end-stage renal disease,
with more than 300,000 needing dialysis (Go et al. 2004).
CKD is known as one of the possible complications of
Acute Kidney Injury (AKI). Kidney ischemic/reperfusion
injury (IRI) can cause AKI and more than 70% of AKI
cases will develop into CKD (Bonventre and Yang 2011).
Reactive oxygen species can cause kidney insufficiency
(Arfian et al. 2012), by inducing interstitial cells expan-
sion and extracellular matrix production, which inhibits
tubular epithelial cell proliferation in kidney IRI models
(Kim et al. 2010). Interstitial area expansion leads to kid-
ney interstitial fibrosis, which is known as themain charac-
teristic of progressive kidney disease (Strutz and Zeisberg
2006).
Kidney fibrosis is mediated by fibroblast accumula-
tion and dysfunction. Fibroblast dysfunction causes ane-
mia due to the reduction of erythropoietin (EPO), the hor-
mone that stimulates erythropoiesis (Asada et al. 2011).
One study using in situ hybridization and transgenic mice
found that EPO was produced by interstitial fibroblast at
the inner cortex and outer medulla (Obara et al. 2008).
Patients with CKD also show increases of inflammatory
molecules; for example, C-reactive protein (CRP), and
groups of cytokines such as IL1, IL6 and TNF alpha
(Bergström and Lindholm 2000; Stenvinkel 2001). Proin-
flammatory cytokines can cause EPO resistance by dis-
rupting iron metabolism (Donovan et al. 2005).
Subtotal nephrectomy and unilateral ureteral obstruc-
tion are known as models for CKD, whereas IRI is known
as a model for AKI in mice (Arfian et al. 2012; Asada et al.
2011). In this study, the IRI model was used to induce
CKD, especially in the chronic period of IRI. IRI could
also induce CKD and kidney fibrosis after 12 days based
on the histopathological findings, as shown by fibroblast
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proliferation as well as myofibroblast expansion, which is
also associated with anemia (Asada et al. 2011). Studies
on the chronic effect of single and repeated kidney IRI and
the process of how AKI develops into CKD in this model
are still rare. Therefore, it is necessary to investigate the
chronic effect of kidney IRI, especially interstitial cells ex-
pansion (fibroblasts and pericytes). The correlation of in-
terstitial cells’ expansion with hemoglobin concentration
and EPO expression in this model is also rarely investi-
gated, so it is equally important to be studied.
2. Materials andmethods
This was a quasi-experimental study with a post-test
only controlled group design using 24 Swiss male mice,
three months old, weighing 30–40 grams. Mice were
obtained from the Integrated Research and Analytical
Laboratory (Laboratorium Penelitian dan Pengujian Ter-
padu), Universitas Gadjah Mada, Yogyakarta, Indone-
sia. The animals were randomized and maintained un-
der standard laboratory conditions and given access ad
libitum to an animal diet and tap water. All experimen-
tal procedures were conducted in accordance with the
Medical and Health Research Ethics Committee, Faculty
of Medicine, Universitas Gadjah Mada, with expediency
number KE/FK/845/EC.
2.1. Kidney ischemic/reperfusion injury model
Animal subjects were divided into four groups that
contained six mice each: control/sham operation (SO),
ischemic/reperfusion 1 (IR1), ischemic/reperfusion 12
(IR12), and ischemic/reperfusion 7-12 (IR7-12). Sham op-
eration was used as the control, IR1 was used as the AKI
model, IR12 was used as the chronic single IRI model, and
IR7-12 was used as the repeated IRI model.
The kidney IRI model was performed under general
anesthesia. Intraperitoneal injection of pentobarbital so-
lution 1:10 (0.1mg/10 gramBW) was used as the anesthe-
sia agent. In this model, we performed clamping of the
right and left renal pedicles using a non-traumatic vascu-
lar clamp (Karl Hammacher GmbH, Solingen, Germany)
for 30 min. After 30 min, the clamp was released and fol-
lowed by reperfusion. The incised skin and peritoneum
were then closed using surgical thread silk 3/0 (OneMed-
Healthcare, Surabaya, Indonesia).
In the SO group, no pedicle clamping was performed,
only an abdominal incision followed by the closing of the
incised skin. This group was euthanized on day 12. In the
IR1 and IR12 groups, bilateral renal pedicle clamping was
performed on day 0 and subjects were euthanized on days
1 and 12, respectively. In group IR7-12, bilateral renal
pedicle clampingwas performed on days 0 and 7, followed
by euthanasia on day 12.
2.2. Blood serum analysis
Whole blood was obtained from the retro-orbital vein
for the measurement of hemoglobin and creatinine levels.
Whole blood samples for hemoglobin measurement were
transferred into an EDTA tube, whereas whole blood sam-
ples for creatininemeasurement were transferred into a 1.5
mL tube followed by centrifugation at 10,000 rpm for 10
min. Supernatants were obtained as the blood serum and
all samples were brought to the Clinical Pathology Labo-
ratory, Faculty of Medicine, Public health, and Nursing,
Universitas Gadjah Mada, for hemoglobin and creatinine
measurement.
2.3. Microscopic analysis
2.3.1. Tubular injury score
To measure the tubular injury score, the kidneys were
embedded in paraffin blocks and 4 µm sections were
stained with periodic acid-Schiff (PAS), examined with
an Olympus CX22 light microscope (Olympus Corpora-
tion, Tokyo, Japan), and portrayed using the Optilab soft-
ware at 100x magnification at the corticomedullary junc-
tion area. Tubular injury scores were determined using a
semi-quantitative scoring system. Fifteen fields per kid-
ney were examined and injuries were graded from 0–4
(0, normal; 1, injury affecting <25%; 2, injury affecting
25–50%; 3, injury affecting 50–75%; 4, injury affecting
>75%), according to these variables: renal tubular atrophy
and dilatation, intraluminal cast formation (reddish color
inside the lumen in PAS staining), loss of brush border,
accumulation of inflammatory cells, and intraluminal cast
(Park et al. 2012).
2.3.2. Immunohistochemical staining
The kidneys were embedded in paraffin blocks and 4 µm
sections were made, deparaffinized and rehydrated using
100%, 90%, 80%, and 70% alcohol, followed with the
heating process in citrate buffer (pH 6) for antigen retrieval
and blocking endogenous peroxidase using H202 3% in
PBS solution. The slides were then incubated using Back-
ground Sniper, rabbit 1st monoclonal antibody PDGFRβ
with 1:200 dilution (Abcam, ab32570, Cambridge, United
Kingdom), TrekAvidin-HRP, 2nd antibody anti-rabbit
Trekkie Universal Link (Biocare Medical, STUHRP700,
California, United States), and diaminobenzidine tetrahy-
drochloride (Biocare Medical, STUHRP700H L10). The
results were analyzed using the ImageJ software, exam-
ined with a light microscope (Olympus CX22), and por-
trayed with the Optilab software at 400x magnification.
2.4. Reverse transcriptase PCR analysis
2.4.1. RNA extraction and cDNA synthesis
Total RNA was extracted using Genezol (Geneaid
GZR100, Geneaid Biotech Ltd, New Taipei City, Taiwan),
followed by quantification of RNA concentration using
spectrophotometry. We used 3,000 ng RNA for making
cDNA. The cDNA was made using Rever Tra Ace® (Toy-
obo Cat. No. TRT-101, Osaka, Japan) and random primer
(Toyobo Cat. No. 3801), with PCR conditions: 30°C for
10 min (denaturation), 42°C for 60 min (annealing) and
99°C for 5 min (extension).
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2.4.2. Reverse transcriptase PCR and electrophoresis
Reverse transcriptase PCR was carried out to am-
plify the following specific cDNAs: erythropoietin (F:
AGGAATTGATGTCGCCTCCA and R: AGCTTGCA-
GAAAGTATCCACTGTG); CD68 (F: CATCAGAGC-
CCGAGTACAGTCTACC and R: AATTCTGCGC-
CATGAATGTCC); monocyte chemoattractant protein-
1/MCP-1 (F: GGCATCACAGTCCGAGTCACAC and R:
CTACAGACAACCACCTCAAGCACTTCTGT), and
GAPDH (F: GGCACAGTCAAGGCTGAGAATG and
R: TCTCGCTCCTGGAAGATGGTGA).
The reverse transcriptase PCR was performed by mix-
ing 2 μL cDNA, 12.5 μL of Taq Master Mix (Bioron, Ger-
many, Cat. No. S101705), 0.6 μL of forward and reverse
primer, and 9.3 μL of PCR water. The cDNA were am-
plified to the following conditions: 94°C for 2 s (initial
denaturation), 94°C for 10 s (denaturation), 60°C for 20
seconds (annealing), 72°C for 1min (extension), and 72°C
for 10 min (last extension) for 35 cycles. The PCR prod-
ucts were analyzed in 2% agarose gel along with a 100 bp
DNA ladder (Bioron Cat. No. 306009, Germany). Ex-
(a)
(b)
FIGURE 1 Results for mean hemoglobin levels (a) and mean
creatinine levels (b). SO, control/sham operation; IR1, is-
chemic/reperfusion; IR12, ischemic/reperfusion 12; IR7-12,
ischemic/reperfusion 7-12. Data were analyzed using one-way
ANOVA (p = 0.000) and Kruskal Wallis (p = 0.000) tests. Asterisks
show significance between SO and IRI groups (***, p < 0.001; **, p <
0.01; *, p < 0.05). Elbow connectors show significances between IRI
groups (##, p < 0.001; ±, p < 0.01; #, p < 0.05).
pressions of the gene were quantified with densitometry
analysis using the ImageJ software. GAPDH was used as
the housekeeping gene.
2.5. Results analysis
The data obtained were analyzed using the Shapiro Wilk
test for distribution analysis. The Pearson correlation and
Spearman correlation tests were used if the data were nor-
mally and abnormally distributed, respectively, with p <
0.05 used to determine the level of significance. Multiple
comparisons among the groups were made using one-way
ANOVA and followed by post hoc LSD tests if the data
were normally distributed. If the data were abnormally
distributed, Kruskal Wallis and post-hoc Mann Whitney
tests were used, with p < 0.05 used to determine the level
of significance.
3. Results
3.1. Blood serum analysis
Single chronic and repeated kidney IRI induced a de-
crease in hemoglobin levels, as shown in the significantly
lower values in groups IR12 and IR7-12 compared with
the SO group (p < 0.01). Single acute kidney IRI, repre-
sented by the IR1 group, also induced significantly lower
hemoglobin levels compared with SO, but in smaller de-
creases compared with the IR12 and IR7-12 groups (Fig-
ure 1a). This result suggests that more chronic and more
severe conditions caused greater decreases in hemoglobin
levels. The decrease in hemoglobin levels in all groups
compared with SO was associated with EPO resistance.
Compared with the SO group, single acute and single
chronic kidney IRI induced significantly higher creatinine
levels, as shown in both the IR1 and IR12 groups. How-
ever, repeated kidney IRI (IR7-12 group) did not show
a significant difference compared with SO. Furthermore,
single chronic (IR12 group) and repeated (IR7-12) kidney
IRI showed lower creatinine levels compared with single
acute (IR1 group) kidney IRI (Figure 1b). The decrease in
creatinine levels from group IR1 to IR12 suggests a repair
phase of IRI starting in day 7 occurred in the IR12 group.
3.2. Microscopy analysis
Kidney IRI induced tubular injury, which was character-
ized by intraluminal cast formation, dilatation, epithelial
effacement, and brush border loss (Figure 2a). Higher
magnification of PAS staining revealed that repairing of
tubular epithelial cells occurred in the IR12 group, as in-
dicated by brush border formation. However, the regen-
eration and tubular repair did not occur in repeated IRI
(IR7-12 group). Quantification of the tubular injury score
showed a significantly higher tubular injury score in the
IR1, IR12, and IR7-12 groups compared with the SO
group (p < 0.001). The IR1 and IR7-12 groups demon-
strated higher tubular injury compared with the IR12
group (Figures 2a, 2b, and 2d). This condition suggested
that the repair phase occurred in group IR12. Microscop-
ically, the IR12 group revealed a regeneration process of
tubular epithelial cells (Figures 2a, 2b, and 2c).
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(a)
(b)
(c)
(d) (e)
FIGURE 2Histological quantification of tubular injury and PDGFRβ-positive cells. (a) Representative figures of PAS staining. Control/sham
operation (SO) group represents normal tubules with brush border (black triangles); tubular injury showed damage of tubular with cast for-
mation (red color), brush border loss (white arrow) and epithelial cell effacement (black arrow) in ischemic/reperfusion (IRI) 1 (IR1), IR12, and
IR7-12 groups. Brush border regeneration could be found in IR12 group. Scale bar = 100 µm. (b) Microscopic figures of kidney tissue. Scale
bar = 100 µm. (c) Microscopic figures of PDGFRβ positive cells. PDGFRβ-positive cells were shown by black arrow. Scale bar = 100 µm. (d)
Results of tubular injury score. (e)NumberofPDGFRβ-positive cells. Tubular injury scoreswereanalyzedusingKruskalWallis test (p=0.001).
Number of PDGFRβ-positive cells were analyzed using one-way ANOVA (p = 0.000). Asterisks show significance between SO and IRI groups
(***, p < 0.001; **, p < 0.01; *, p < 0.05). Elbow connectors show significances between IRI groups (##, p < 0.001; ±, p < 0.01).
Kidney IRI induced a significant increase in the the
number of positive PDGFRβ (fibroblast) cells in the IR1,
IR12, and IR7-12 groups compared with the SO group.
This condition was associated with a severe injury that
leads to interstitial cell (fibroblasts and pericytes) expan-
sion (Figures 2c and 2e).
3.3. RT-PCR analysis
Kidney IRI induced a significantly higher mRNA expres-
sion of EPO in the IR1, IR12, and IR7-12 groups com-
pared with the SO group. This suggests that hypoxia, ei-
ther in an acute or chronic condition, induces production
of HIF and subsequently leads to EPO production (Fig-
ures 3a, 3b). RT-PCR of CD68 as a macrophage marker
and MCP-1 as an inflammatory mediator demonstrated in-
flammation with macrophage infiltration occurred in the
IR1, IR12, and IR7-12 groups. A significantly higher ex-
pression of CD68 mRNA was found in the IR1, IR12, and
IR7-12 groups compared with the SO group (Figures 3a,
3b, and 3c), as well as MCP-1 (Figures 3a and 3b). Re-
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peated IRI, as represented by the IR7-12 group, showed a
significantly higher MCP-1 mRNA expression compared
with the IR1 and IR12 groups. These results suggest that
chronic inflammation might be associated with EPO resis-
tance in all groups, thus inducing anemia.
3.4. Correlation test
The Pearson correlation test between the number of
PDGFRβ-positive cells and hemoglobin level showed a
significant, strong, negative correlation (p = 0.000; r =
−0.822), whereas the Pearson correlation test between
the number of PDGFRβ-positive cells and EPO expres-
sion showed a significant, strong, positive correlation (p
= 0.000; r = +0.795).
4. Discussion
This study found that a reduction of hemoglobin levels
occurred in kidney IRI, which might be associated with
inflammation and macrophage infiltration. Kidney IRI
causes an imbalance between vasoconstriction and vasodi-
lation mediators, which contributes to microvascular and
tubular injury. Microvascular injury is represented by an
increase of vasoconstriction and decrease of vasodilation
response, endothelial and vessel smooth muscle cells in-
jury, leucocyte-endothelial interaction, and inflammation.
Tubular injury induces cytoskeleton damage, loss of po-
larity, apoptosis, and necrosis (Bonventre and Weinberg
2003).
The tubular injury might occur in an acute and chronic
time after the kidney IRI model. Morphological changes
in kidney microstructure demonstrate tubular injury char-
acterized by a loss of the brush border at proximal tubules,
intraluminal cast accumulation, tubular renal dilatation
and atrophy, and accumulation of inflammatory cells in all
IRI groups. Tubular injury also induces degradation of cel-
lular debris into the tubular lumen and contributes to cast
formation (Bayati et al. 1990), tubular lumen obstruction,
and an increase in tubular pressure (Mason et al. 1977).
Tubular injury score quantification showed that the
IR1, IR12, and IR7-12 groups had significantly higher
scores than the SO group. The highest tubular injury score
was in group IR7-12, followed by IR1. Mechanisms and
processes that occurred in the IR1 group showed that tubu-
lar epithelial cell injury is the main mechanism in the ini-
tiation phase of kidney injury (Sutton et al. 2002). How-
ever, based on our result, in day 12 following IRI (IR12
group) and repeated kidney IRI (IR7-12 group), tubular in-
jury still occurred, represented by delayed epithelial cells
and an inadequate regeneration process. This result also
revealed that there was a repairing process in the recov-
ery phase of kidney IRI. In this phase, cell differentiation
continues, epithelial polarity is regained, and organ func-
tions normally return (Hagmann et al. 2011; Harris 1997;
Schena 1998). The IR7-12 group represents the model for
a maladaptive repair response. Second IRI in the IR7-12
group represented the disruption of themaintenance phase,
which leads to a maladaptive repairing process.
(a) (b)
(c)
FIGURE 3mRNA and protein expression of pro-inflammatory mediators. (a) Gel electrophoresis figures of RT-PCR analyses of MCP-1, EPO,
CD68, and GAPDH from kidney tissue. (b) Bar charts of relative quantification for mean EPO/GAPDH, CD68/GAPDH and MCP-1/GAPDH
mRNA expressions. Data were analyzed using one-way ANOVA (p = 0.000). Asterisks show significances between SO and IRI groups (***, p <
0.001; **, p < 0.01). Elbow connectors show significances between IRI groups (##, p < 0.001; #, p < 0.05). (c) Immunohistochemistry showing
CD68 asmacrophagemarker to demonstrate inflammation (white arrows) in groups IR1, IR12, and IR7-12. Scale bar = 100 µm.
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Repeated injury in the IR7-12 group also demon-
strated the highest number of PDGFRβ-positive cells, fol-
lowed by the IR12 group. We chose PDGFRβ as the
marker for fibroblasts and pericytes in this study, although
there are other markers, such as NG2, that can also be used
to examine these two kinds of cells. Both fibroblast expan-
sion and myofibroblast formation not only change fibrob-
last structure, but its functions, as well (Asada et al. 2011).
More hypoxic induces chronic hypoxia, which leads to
tubulointerstitial injury (Bonventre and Yang 2011). Mal-
adaptive repair leads to fibroblast activation and tubuloin-
terstitial fibrosis, chronic and excessive profibrotic cy-
tokines production by activated macrophages. IL13 and
TGF β-1 are some of the profibrotic cytokines produced
(Bonventre and Yang 2011). Hypoxic inducible factor
1α (HIF-1α ) may also contribute to the chronic effect
of hypoxia that may lead to fibrosis. HIF increases in
the acute phase of IRI and provides protective effects in
the acute phase of ischemia injury. However, in the re-
nal fibrosis model, deletion of HIF-1α may prevent ep-
ithelial to mesenchymal transition and tubulointerstitial fi-
brosis (Higgins et al. 2007). Prolonged activation of HIF-
1α could also induce the upregulation of profibrotic sub-
stances, such as connective tissue growth factor. This
upregulation stimulates fibrosis and destruction of renal
prenchyme (Haase 2013). Examining fibroblast to myofi-
broblast formation in this studymay shed light on the EPO-
producing cells, especially the periods of kidney IRI.
RT-PCR analysis showed an increase of EPO mRNA
expression in groups IR1, IR12, and IR7-12. The Pear-
son correlation test between the number of PDGFRβ-
positive cells and EPO expression showed a significant,
strong, positive correlation (p = 0.000; r = +0.795). This
positive correlation indicated that the higher the number
of PDGFRβ-positive cells, the higher the EPO that was
produced. Meanwhile, the same test between the num-
ber of PDGFRβ-positive cells and hemoglobin concen-
tration showed a significant, strong, negative correlation
(p = 0.000; r = −0.822). It can be concluded that the
greater the number of PDGFRβ-positive cells, the greater
the decrease in hemoglobin levels. This study showed
that the correlation between number of PDGFRβ-positive
cells with hemoglobin concentration and creatinine level
trended in opposite directions. It can be induced by
chronic inflammation, which becomes the basis for EPO
resistance in CKD models. This condition may need fur-
ther examination of the proliferation of fibroblasts. Prolif-
erated fibroblasts may transform into myofibroblasts, thus
reducing the EPOproduction from fibroblasts (Asada et al.
2011). In this study, we found that anemia still occurred in
spite of the increased mRNA expression of EPO. Further
analysis of the phenotype of the fibroblast is necessary for
the completion of this study. Double immunostaining to
examine the fibroblast to myofibroblast transition or EPO
immunostaining may be considered important to continue
this research. We consider this matter to be one of the lim-
itations of this study. In CKD cases, anemia can be due
to EPO deficiency and resistance, as well as disruption in
iron metabolism (Hörl 2013), and it may be related to in-
flammation.
Inflammation plays a role in the pathogenesis of kid-
ney injuries. Inflammation occurs in both acute and
chronic phases of kidney injury, and further contributes
to maladaptive responses (Akcay et al. 2009). This pro-
cess activates proinflammatory cytokines and chemotac-
tic agents, such as TNF-α, MCP-1, IL- 8, IL-6, TGF-β,
regulated on activation, normal T expressed and secreted
(RANTES) protein, and epithelial neutrophil-activating
protein 78 (ENA-78), and then induces macrophage
infiltration (Basile and Yoder 2014). We elucidated
macrophage infiltration through the expression of mRNA
and protein CD68 as the macrophage marker. CD68 ex-
pression was increased in groups IR1, IR12, and IR7-
12, and was significantly different from group SO. Im-
munostaining revealed infiltration of the macrophage in
IR groups, which was associated with the upregulation of
MCP-1 and CD68mRNA expression. This result could be
due to chronic inflammation in groups IR12 and IR7-12,
which leads to chronic and excessive production of profi-
brotic cytokines. Anemia in CKD is a type of anemia of
chronic disease (Weiss and Goodnough 2005). The ACD
is characterized by a blunted EPO response, decrease of
red blood cells age, and defects in iron metabolism, con-
sisting of decreases in iron absorption and iron retention
by macrophages (Weinstein et al. 2002).
Macrophage infiltration leads to macrophage polariza-
tion andM1 formation due to inflammatory mediator stim-
ulation. M1 plays a main role in inflammation modulation
and inducing tissue damage (Cao et al. 2015). Prolonged
inflammation also induces a production on hepcidin in the
liver. Hepcidin can degrade transmembrane protein ferro-
portin (Fpn) in M1. This condition prevents the release of
iron into the extracellular environment, and thus iron will
undergo sequestration in M1 and the inflammation area.
A chronic increase of hepcidin and iron sequestration re-
duces iron levels in the blood and finally induces anemia
(Cairo et al. 2011). Kidney IRI upregulates inflammatory
cytokines production, then induces M1 formation and iron
sequestration. Proinflammatory cytokines, such as TNFα,
IL-1β, and IL-6, may also upregulate hepcidin (Gammella
et al. 2014). Elucidating proteins that contribute to iron
metabolism, such as hepcidin or transferrin, may provide
a better understanding of the effect of IRI on anemia and
EPO production. In the future, it is also necessary to ex-
amine the possibility of iron entrapment and deposition in
the kidney after IRI.
5. Conclusions
In conclusion, chronic effects of single and repeated IRI
cause interstitial cells expansion and an elevation in EPO
mRNA expression. The decrease in hemoglobin levels
could be caused by chronic inflammation that inhibits
EPO effectiveness. Therefore, our study revealed that
chronic and repeated kidney ischemic/reperfusion injury
induced fibroblast expansion and inflammation associated
with anemia.
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